Order Article Reprints

Onoe H, Hirooka K, Baba T, Nagayama M, Hirota A, Suzuki K, Sagara T, Mochizuki H, Kiuchi Y. The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients. Journal of Clinical Medicine. 2024; 13(14):4158. https://doi.org/10.3390/jcm13144158

Onoe, Hiromitsu, Kazuyuki Hirooka, Tetsuya Baba, Mikio Nagayama, Atsushi Hirota, Katsuyoshi Suzuki, Takeshi Sagara, Hideki Mochizuki, and Yoshiaki Kiuchi. 2024. "The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients" Journal of Clinical Medicine 13, no. 14: 4158. https://doi.org/10.3390/jcm13144158

Onoe, H., Hirooka, K., Baba, T., Nagayama, M., Hirota, A., Suzuki, K., Sagara, T., Mochizuki, H., & Kiuchi, Y. (2024). The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients. Journal of Clinical Medicine, 13(14), 4158. https://doi.org/10.3390/jcm13144158